RecruitingNCT04890067
Observational Study in Localized Osteosarcoma
Multicenter Observational Study on the Treatment of Patients With Localized Osteosarcoma
Sponsor
Italian Sarcoma Group
Enrollment
120 participants
Start Date
Jul 30, 2021
Study Type
OBSERVATIONAL
Conditions
Summary
Observational prospective trial aimed to collect the collect demographic, clinical, surgical, pathological and molecular characteristics and treatment from patients affected by localized OsteoSarcoma (OS) treated according the AIEOP/Italian Sarcoma Group (ISG) OS 2021
Eligibility
Max Age: 40 Years
Inclusion Criteria5
- Diagnosis of high grade OS of the extremities
- Age at diagnosis ≤ 40 years at the time of diagnosis
- Localized disease (skip metastases are allowed)
- Adequate organ function according the AIEOP/ISG OS 2021 recommendation
- Patients or parents oe guardians of minors who have given their written informed consent to participate in the study
Exclusion Criteria3
- Presence of metastases
- Diagnosis of periosteal OS, of parosteal OS or secondary OS
- Any medical condition which can not allowed the use of the treatments recommended by AIEOP/ISG OS 2021
Interventions
OTHERTreatment of Osteosarcoma according the AIEOP/ISG OS 2021 recommendations (includes drugs, surgery, radiotherapy or any other received treatments)
This observational study collects all the treatments received by the patients according according the AIEOP/ISG OS 2021 and therefore includes drug/biological/surgical/ radiotherapy and any other applicable treatments
Locations(16)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04890067